ID   OCI-C4p
AC   CVCL_DH05
SY   OCI-C4P; OCIC4P
DR   cancercelllines; CVCL_DH05
DR   DepMap; ACH-001719
DR   ECACC; 20012002
DR   GEO; GSM1001397
DR   GEO; GSM1001434
DR   Wikidata; Q54931751
RX   PubMed=26080861;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Unspecified (PubMed=26080861).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): DepMap=ACH-001719; PubMed=26080861
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 15
ST   D21S11: 27,29
ST   D3S1358: 15,18
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 25
ST   Penta D: 13
ST   Penta E: 7,15
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 02-05-24; Version: 15
//
RX   PubMed=26080861; DOI=10.1038/ncomms8419;
RA   Ince T.A., Sousa A.D., Jones M.A., Harrell J.C., Agoston E.S.,
RA   Krohn M., Selfors L.M., Liu W.-B., Chen K., Yong M., Buchwald P.,
RA   Wang B., Hale K.S., Cohick E., Sergent P., Witt A., Kozhekbaeva Z.M.,
RA   Gao S.-Z., Agoston A.T., Merritt M.A., Foster R., Rueda B.R., Crum C.P.,
RA   Brugge J.S., Mills G.B.;
RT   "Characterization of twenty-five ovarian tumour cell lines that
RT   phenocopy primary tumours.";
RL   Nat. Commun. 6:7419.1-7419.14(2015).
//